Recent investigations suggested that SIRT1, a critical metabolic regulator, and its enzymatic activity may be regulated by cellular energy, significantly improving disease progression in animal models of NAFLD [149,150,151,152]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.